Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta-Reference-Cited by-同舟云学术

Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta

Published:2013-06-05 Issue:7 Volume:88 Page:594-600
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Cairoli Roberto¹²,Beghini Alessandro³,Turrini Mauro¹,Bertani Giambattista⁴,Nadali Gianpaolo⁵,Rodeghiero Francesco⁶,Castagnola Carlo⁷,Lazzaroni Francesca³,Nichelatti Michele¹,Ferrara Felicetto⁸,Pizzolo Giovanni⁵,Pogliani Enrico⁹,Rossi Giuseppe¹⁰,Martinelli Giovanni¹¹,Morra Enrica¹

Affiliation:

1. Division of Haematology; Niguarda Hospital; Milan Italy

2. Division of Haematology; Department of Internal Medicine; Valduce Hospital; Como Italy

3. Department of Medical Biotechnology and Translational Medicine; University of Milan; Milan Italy

4. Division of Transfusion Medicine; Niguarda Hospital; Milan Italy

5. Department of Clinical and Experimental Medicine; University of Verona; Verona Italy

6. Department of Haematology; San Bortolo Hospital; Vicenza Italy

7. Department of Haematology Oncology; University of Pavia & Fondazione IRCCS Policlinico San Matteo; Pavia Italy

8. Division of Haematology and Stem Cell Transplantation Unit; Cardarelli General Hospital; Naples Italy

9. Division of Hematology and Bone Marrow Transplantation Unit; San Gerardo University Hospital; Monza Italy

10. Department of Haematology; Spedali Civili; Brescia Italy

11. Division of Haematology and Stem Cell Transplantation Unit; Bologna Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23461/fullpdf

Reference50 articles.

1. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B study;Marcucci;J Clin Oncol,2005

2. Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes;Kuwatsuka;Blood,2009

3. Trisomy 22 in acute myeloid leukemia: A marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16;Wong;Cancer Genet Cytogenet,1999

4. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia: A unique cytogenetic clinicopathological association;Beau;N Engl J Med,1983

5. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461);Byrd;Blood,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Power of Machine Learning Models for Relapse Outcomes in Acute Myeloid Leukemia: Unveiling Key Genes and Pathways for Improved Patient Management;2023-12-07

2. How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring;Biomedicines;2021-08-03

3. Co-occurrence of KIT and NRAS mutations defines an adverse prognostic core-binding factor acute myeloid leukemia;Leukemia & Lymphoma;2021-05-24

4. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21);Blood Advances;2021-05-18

5. Core-binding factor beta is required for osteoblast differentiation during fibula fracture healing;Journal of Orthopaedic Surgery and Research;2021-05-14